Tuesday, 17 January 2017

Alcobra's ADHD drug fails late-stage study

(Reuters) - Israeli drug developer Alcobra Ltd on Tuesday said its experimental drug to treat attention deficit hyperactivity disorder (ADHD) failed a late-stage study in adult patients.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)